Plastomics closes $7.1M Series A
“It’ll allow us to get the trait delivery system from the lab through the greenhouse to the field, for both soybeans and corn,” CEO Martha Schlichter told the 4thEst8.
Read More
Author: Paul Riat
Geneoscopy closes $105M Series B
The screening technology examines RNA in a stool sample to detect the cancer, but this simple test is just the first of what CEO Andrew Barnell has told the 4thEst8 in the past that he hopes will be a platform of tests. Broadening this technology could be used to detect, prevent, and guide treatment of a wide variety of gastrointestinal diseases.
Read More
GiftAMeal hires; CEO shares two-pronged expansion plan
GiftAMeal hired two key workers to execute on an expansion plan that CEO Andrew Glantz says he's...
Read More
CareSignal bought by Lightbeam
“It is deeply humbling and rewarding to have grown this company with our phenomenal team, client-partners, and investors,” CareSignal CEO Blake Marggraff said. “I look forward to serving millions of additional patients and members in the years ahead.”
Read More
$3800 Awarded at OPO Startups Pitch Competition
“Pitch competitions like this encourage early stage tech startups to keep doing what they do,” OPO Startups owner, and serial entrepreneur, Randy Schilling told the 4thEst8. “Startups, especially tech startups, drive economic growth and job growth in the region.”
Read More